Efficacy and safety of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric cancer (mGC) with or without prior gastrectomy: Results from a phase III study (TAGS).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David H. Ilson, Aliaksandr Prokharau, Hendrik-Tobias Arkenau, Michele Ghidini, Kazumasa Fujitani, Eric Van Cutsem, Peter C. Thuss-Patience, Giordano D. Beretta, Wasat Mansoor, Edvard Zhavrid, Maria Alsina, Ben George, Daniel V.T. Catenacci, Robert E. Winkler, Lukas Makris, Toshihiko Doi, Kohei Shitara
Institutions: Memorial Sloan Kettering Cancer Center, Sarah Cannon Research Institute, University College London, Osaka Prefectural Medical Center, KU Leuven, Charité – Universitätsmedizin Berlin, Humanitas Gavazzeni, The Christie Hospital, The Christie NHS Foundation Trust, N.N. Alexandrov National Cancer Centre, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, Medical College of Wisconsin, University of Chicago Medical Center, Taiho Oncology (United States), National Cancer Center Hospital East
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2912477352